EUVIMEDEUVIMED entdecken
EditorialKommentar

Trials and Tribulations — The Challenges of Clinical Trials in Children

Susan L Furth

NEJM Evidence · 2023

DOI: 10.1056/evide2300280 ↗

Kurz gefasst

Editorial in der Zeitschrift NEJM Evidence, 2023. Verfasst von Susan L Furth. Beteiligte Einrichtung: Research Institute, Children's Hospital of Philadelphia, Philadelphia. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Diabetes Mellitus, Type 2, Glucosides, Metformin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsDiabetes Mellitus, Type 2GlucosidesMetforminAdolescentChildHumansBlood GlucoseDouble-Blind MethodDrug Therapy, CombinationHypoglycemic AgentsTreatment OutcomeUnited StatesAdamantaneDipeptides

Substanzen

Benzhydryl CompoundsBlood GlucoseGlucosidesHypoglycemic AgentsMetformindapagliflozinempagliflozinsaxagliptinAdamantaneDipeptides

Autor:innen und Institutionen

  • Research Institute, Children's Hospital of Philadelphia, Philadelphia.
  • Division of Nephrology, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.

Zitieren

APA

Furth, S. L. (2023). Trials and Tribulations — The Challenges of Clinical Trials in Children. NEJM Evidence. https://doi.org/10.1056/evide2300280

Vancouver

Furth SL. Trials and Tribulations — The Challenges of Clinical Trials in Children. NEJM Evidence. 2023. doi:10.1056/evide2300280

BibTeX
@article{Furth2023,
  author = {Furth, Susan L},
  title = {Trials and Tribulations — The Challenges of Clinical Trials in Children},
  journal = {NEJM Evidence},
  year = {2023},
  doi = {10.1056/evide2300280}
}
Kostenlos starten →